Marta Vachova

Head doctor

Krajská zdravotní as Nemocnice Teplice oz

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Marta Vachova is the Head Doctor at Krajská zdravotní as Nemocnice Teplice oz in the Czech Republic. Her research primarily focuses on multiple sclerosis, with recent publications exploring treatment strategies, registry data trends, and the effects of pregnancy and vaccination on the disease. She contributes to the understanding of real-world implications for patients through her analysis of the Czech National MS Registry.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Michal Novotny

CZECH REPUBLIC

View details

Jiří Drahota

General University Hospital in Prague

CZECH REPUBLIC

View details

Dominika Stastna

Charles University and General University Hospital in Prague, First Faculty of Medicine

CZECH REPUBLIC

View details

Petra Hanulikova

Charles University

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marta Vachova

Research Interests

Contact this professor

About

Articles (10)

Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

Is breastfeeding in MS harmful or not? An answer from real-world Czech data

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection (vol 65, 104014, 2022)

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014] (Multiple Sclerosis and Related Disorders (2022) 65, (S2211034822005235), (10.1016/j.msard.2022.104014))

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic

Collaborators (4)

Michal Novotny

Jiří Drahota

Dominika Stastna

Petra Hanulikova

Make your next move.